MedPath

chemotherapy for primary bone sarcoma over 41 except for Ewing sarcoma

Not Applicable
Conditions
primary bone sarcoma
Registration Number
JPRN-UMIN000023089
Lead Sponsor
Gifu Gfraduate University school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

<41 years old low grade malignancy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5 year overall survival
Secondary Outcome Measures
NameTimeMethod
5 year progression free survival
© Copyright 2025. All Rights Reserved by MedPath